Spears Abacus Advisors LLC Pfizer Inc Transaction History

Spears Abacus Advisors LLC

$4.73 Billion
Q3 2024

A detailed history of Spears Abacus Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Spears Abacus Advisors LLC holds 213,678 shares of PFE stock, worth $5.65 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

213,678

Previous 212,223 0.69%

Holding current value

$5.65 Million

Previous $5.94 Million 4.14%

% of portfolio

0.13%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $40,303 - $45,672	1,455 Added 0.69%	213,678 $6.18 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $228,603 - $267,880	-9,050 Reduced 4.09%	212,223 $5.94 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $4.62 Million - $5.3 Million	178,398 Added 416.09%	221,273 $6.14 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $16,398 - $18,972	-454 Reduced 1.05%	42,875 $1.57 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $206,662 - $269,775	-4,950 Reduced 10.25%	43,329 $2.22 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $857,100 - $1.27 Million	20,743 Added 75.33%	48,279 $2.85 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $98,125 - $126,050	-2,500 Reduced 8.32%	27,536 $1.18 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $172,367 - $195,264	4,800 Added 19.02%	30,036 $1.18 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $301 - $339	-9 Reduced 0.04%	25,236 $914,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $77,683 - $98,781	-2,321 Reduced 8.42%	25,245 $929,000
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $37,528 - $44,029	1,182 Added 4.48%	27,566 $1.01 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $3,012 - $3,654	-100 Reduced 0.38%	26,384 $863,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $17,380 - $24,832	643 Added 2.49%	26,484 $864,000
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $75,419 - $85,591	2,291 Added 9.73%	25,841 $1.01 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $460,838 - $597,571	14,184 Added 151.44%	23,550 $846,000
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $6,309 - $7,193	-164 Reduced 1.72%	9,366 $409,000
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $3,309 - $4,013	-96 Reduced 1.0%	9,530 $420,000
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $24,405 - $26,018	-740 Reduced 7.14%	9,626 $349,000
Q2 2017 Aug 11, 2017	BUY	N/A	10,366	10,366 $348,000

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spears Abacus Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spears Abacus Advisors LLC with notifications on news.

Account

Spears Abacus Advisors LLC Pfizer Inc Transaction History